• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=8621251).
  

PubMed=3338971; DOI=10.1007/BF02623810
Hirohisa Yano, Masafumi Maruiwa, Shigetaka Sugihara, Masamichi Kojiro, Shinji Noda, Kosaku Eto;
Establishment and characterization of a new human renal cell carcinoma cell line (KRC/Y).
In Vitro Cell. Dev. Biol. 24:9-16(1988)

PubMed=8621251; DOI=10.1002/(SICI)1097-0215(19960503)66:3<322::AID-IJC9>3.0.CO;2-0
Yoshihiko Tomita, Vladimir Bilim, Takashi Kawasaki, Kota Takahashi, Ismail Okan, Kristinn Petur Magnusson, Klas G. Wiman;
Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53.
Int. J. Cancer 66:322-325(1996)

PubMed=10723130; DOI=10.1038/sj.onc.1203449
Andrei Alimov, Maria Kost-Alimova, Jian Liu, Chun-De Li, Ulf S.R. Bergerheim, Stefan Imreh, George Klein, Eugene R. Zabarovsky;
Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma.
Oncogene 19:1392-1399(2000)

PubMed=10929426; DOI=10.1007/s002400000103
Ichiro Shintaku, Nobutoshi Kawagoe, Shigeru Yutani, Sakuo Hoshi, Seiichi Orikasa, Osamu Yoshizumi, Kyogo Itoh;
Expression of the SART1 tumor rejection antigen in renal cell carcinoma.
Urol. Res. 28:178-184(2000)